Recent large cohort studies established that, within normal range, low serum PRL is associated with metabolic syndrome and obesity in children (37), and higher prevalence of impaired glucose intolerance, increased insulin resistance, polycystic ovary syndrome (PCOS), nonalcoholic fatty liver disease (NAFLD), and increased risks of new onset T2D in both men and women ( In concordance with epidemiologic studies, circulating levels of PRL are reduced in the ob/ob and db/db obese and diabetes mouse models, and in streptozocin-induced (STZ) T2DM rats
These results underscore the high degree of clinical effectiveness of semaglutide in adolescents with obesity, the report concluded
Compounded semaglutide is a customized version of the medication, prepared by our partner, Belmar Pharma Solutions
By week 12, cumulative weight loss of 56% of baseline body weight is common in clinical trials, though individual results vary